CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1Wannisa Khamaikawin(King Mongkut's Institute of Technology Ladkrabang), Suradej Hongeng(Ramathibodi Hospital)Scientific ReportsMay 13, 202410.1038/s41598-024-61626-xCited by 16SaveCiteExport RISWatch citationsRelated PapersHypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal-regulated kinase signaling pathway|Molecular Medicine Reports|2015|29Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major|PLoS ONE|2017|16